The Magentiq-Colo, created by Israel-based technology company Magentiq-Eye, is one of the only AI-powered colonoscopy systems in the U.S., according to a July 31 news release from the company.
Colorectal cancer is the third-leading cause of cancer related death in the U.S., and a missed polyp during a colonoscopy can lead to interval cancer, which accounts for 8 percent to 10 percent of all colorectal cancer cases in the U.S.
In 2022, a 950-patient study cited by Magentiq-Colo found the device increased adenoma detection by 26 percent, which correlates to a 35 percent decrease in patient mortality, the release said.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
